Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd hit its upper circuit at Rs 1,192.95, marking a 5.0% gain within the 5% price band allowed for the day. This ceiling price effectively froze trading, as buyers were willing to purchase at this level but sellers were absent, creating a scenario of unfilled demand. The intraday range was relatively wide, with a low of Rs 1,101.90 and a high at the circuit price, indicating some volatility before the price locked in. The circuit mechanism capped the upside, but the persistent buying interest suggests strong demand pressure — what does the full demand picture look like for Venus Remedies once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Volume on the circuit day was 1.47684 lakh shares, translating to a turnover of ₹17.18 crore. While total traded volume is often suppressed on circuit days due to the price lock, the delivery volume offers a clearer insight into the quality of the move. However, delivery volume on 25 May was 47,120 shares, down by 2.85% against the 5-day average, indicating a slight decline in shares taken for long-term holding. This suggests that while the price moved up to the circuit, the buying may have been driven more by short-term demand rather than a surge in conviction-based accumulation. The weighted average price being closer to the low of the day further supports the notion that some selling pressure existed below the circuit price, but was insufficient to break the ceiling. This nuanced delivery picture raises the question — is Venus Remedies' upper circuit move backed by improving fundamentals or is this a liquidity-driven micro-cap move?

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a bullish trend that preceded the circuit event. The stock has also been on a three-day consecutive gain streak, rising 15.76% over this period, signalling sustained buying interest. The upper circuit on 26 May thus appears to be an amplification of an already positive trend rather than an isolated spike. The intraday price action, with a gap up open of 2.57%, further supports the momentum narrative. Yet, the delivery volume decline tempers the enthusiasm, prompting the question — does the technical strength fully reflect underlying investor conviction or is it partly a function of thin liquidity?

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately ₹1,557 crore, Venus Remedies Ltd is classified as a micro-cap stock. This segment is known for thinner liquidity and more pronounced price swings, making upper circuit hits more frequent and impactful. The stock's liquidity profile allows for a trade size of around ₹0.15 crore based on 2% of the 5-day average traded value, which is modest and highlights the limited institutional-grade liquidity. Such conditions mean that while the upper circuit signals strong demand, the ability to enter or exit sizeable positions without impacting price is constrained. This liquidity risk is a critical consideration for investors — should the limited liquidity temper enthusiasm for chasing the circuit move?

Intraday Price Action

The stock opened with a gap up at Rs 1,157.50, approximately 2.57% above the previous close, and traded within a range of Rs 1,101.90 to Rs 1,192.95. The weighted average price was closer to the low end of this range, indicating that while buyers pushed the price to the circuit, much of the volume was executed at lower levels. This pattern is typical of circuit hits where the price ceiling restricts further upside, and the order book becomes skewed with buyers accumulating at the top price. The narrow range near the circuit price towards the close reflects the freeze in trading activity once the upper limit was reached.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by innovation-driven growth and regulatory complexities. While the stock's recent price action is notable, the fundamental backdrop includes factors such as product pipeline progress, regulatory approvals, and sector dynamics that influence longer-term valuation. The micro-cap status means that fundamental developments can have outsized effects on price, but the current circuit event is primarily a technical phenomenon.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at a 5.0% gain capped the session for Venus Remedies Ltd, reflecting strong buying interest that exceeded the price band allowance. However, the slight decline in delivery volume tempers the conviction narrative, suggesting some speculative or short-term demand may be at play. The stock’s position above all major moving averages confirms an underlying bullish trend, but the micro-cap liquidity constraints mean that the price action is vulnerable to order book imbalances. Investors should weigh the circuit event alongside the limited liquidity and delivery data — is Venus Remedies still worth considering or has the move already happened?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →